Sponsored
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Posted
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
UN walks back 14,000 Gaza baby death claim after backlash
The UN faced backlash after its humanitarian chief, Tom Fletcher, stated 14,000 Gaza babies could...
Trump’s ‘One Big Beautiful Bill’ clears House by one vote after all-night showdown
House Republicans narrowly passed President Trump's "One Big Beautiful Bill," a sweeping tax and...
Uttarakhand CM Dhami chairs meeting to discuss campaign against corruption; visits Shri Hemkunt Sahib
Chief Minister Pushkar Singh Dhami directed officials to intensify the anti-corruption campaign...
Minister Dr Rana meets with Japanese Foreign Minister
KATHMANDU: Minister for Foreign Affairs Dr Arzu Rana Deuba, who is on an official visit to Japan,...